Month: October 2025

Vancouver, Canada, Oct. 21, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the enrollment of the last patient for the first cohort of its Phase I/IIa clinical trial evaluating CMND-100, the Company’s proprietary MEAI-based oral drug candidate for the treatment of Alcohol Use Disorder (AUD). To date, six patients have been successfully enrolled into the trial, Of these, two patients were enrolled at Johns Hopkins University School of Medicine and four at Yale School of Medicine’s Department of Psychiatry. The multinational, multicenter Phase I/IIa trial is designed as a single- and multiple-dose...

JENA, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference. Details are as follows: Guggenheim Securities 2nd Annual Healthcare Innovation ConferenceNovember 10 – 12, 2025 in Boston, MAFireside chat on November 11 at 2:30 PM ET InflaRx will also conduct one-on-one investor meetings on November 11th. A link to view the fireside chat live stream and its replay is available here. About InflaRx InflaRx (Nasdaq: IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5a receptor technologies to discover, develop and commercialize highly...

21 October 2025 Middlefield Canadian Income PCC (the “Company”)Including Middlefield Canadian Income – GBP PC (the “Fund”), a cell of the CompanyRegistered No: 93546 Legal Entity Identifier: 2138007ENW3JEJXC8658 Result of Elections In connection with the proposals for the reconstruction and winding up of Middlefield Canadian Income PCC (the “Company”) and Middlefield Canadian Income – GBP PC (the “Fund”) and the option for Fund Shareholders to receive shares in a newly established, actively managed, listed and London Stock Exchange traded fund in the form of an authorised UCITS (the “ETF”) and/or a cash exit at close to the Fund’s net asset value per share, in exchange for their shareholding in the Fund (the “Scheme”), the Board of the Company today announces the result of the Elections made by Fund Shareholders. Elections for the Cash...

Category: Changes board/management/auditors OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 21 OCTOBER 2025 AT 14:15 PM CHANGES IN BOARD/MANAGEMENT/AUDITORS Markus Souru steps down from his role in Oma Savings Bank’s management team Oma Savings Bank’s Head of service network and member of the management team, Markus Souru, will step down from his role on 21 October 2025. Marku Souru will continue working for the company in other duties until 31 December 2025. Area Director Markus Lauri has been appointed as interim Head of service network. “I would like to take this opportunity to thank Markus Souru for his work in developing the bank’s business, and I wish him all the best for the future,” says Karri Alameri, OmaSp CEO. Oma Savings Bank Plc Additional information: Karri Alameri, CEO, tel. +358 45 656 5250, karri.alameri@omasp.fi Distribution: Nasdaq...

LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) — Limitless X Holdings Inc. (OTCQX: LIMX), a global health, wellness, and lifestyle company founded by entrepreneur Jas Mathur, today announced plans to launch operations in India and select Asian markets in Q1 2026. For Mathur, who was born in New Delhi and raised in Montreal, Canada before building Limitless X in the United States, the expansion represents both a strategic milestone and a personal homecoming. “India gave me my roots. It shaped who I am,” said Mathur. “Now I want to give back to my people, to the community, to inspire them to believe in themselves, prioritize health, and build disciplined, purpose-driven lives.” With India now facing a growing wellness crisis – more than 77 million Indian adults are living with diabetes – Limitless X aims to deliver accessible, science-backed...